Profusa, Inc.
Profusa, Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A Preferred Stock | - | - | 0 | 0 | - | 4 | 0 | 4 | - | - | - | - | |||||
Series C Preferred Stock | - | - | 0 | 0 | - | 8 | 0 | 8 | - | - | - | - | |||||
Undesignated Preferred Stock | - | - | 0 | 0 | - | - | 0 | - | - | - | - | - | |||||
Related Party | - | 0 | 0 | -10 | 8 | 2 | 25 | 0 | 0 | 1 | 1 | 0 | |||||
Series B Preferred Stock | - | - | 0 | 0 | - | 5 | 0 | 5 | - | - | - | - | |||||
Assets Current | |||||||||||||||||
Cash | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Restricted Cash Current | - | - | - | - | 0 | 0 | - | - | - | - | - | - | |||||
Assets Held In Trust Current | - | - | - | - | 1 | - | - | 1 | - | - | 2 | - | |||||
Prepaid Taxes | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | |||||
Cash And Cash Equivalents At Carrying Value | - | 0 | 2 | 3 | - | - | 0 | 0 | 0 | 0 | 0 | - | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 1 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Held In Trust | - | - | - | - | - | - | - | - | - | - | 2 | - | |||||
Crypto Asset Fair Value Current | - | - | 1 | 1 | - | - | - | - | - | - | - | - | |||||
Assets Current | 1 | 1 | 4 | 4 | 1 | 0 | 0 | 1 | 0 | 0 | 2 | 0 | |||||
Assets Held In Trust Noncurrent | - | - | - | - | 1 | 2 | 8 | 8 | 8 | 8 | 9 | 11 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | |||||
Deferred Costs | 0 | 0 | - | - | - | - | 3 | - | - | - | - | - | |||||
Assets | 1 | 1 | 4 | 4 | 2 | 2 | 3 | 9 | 9 | 8 | 11 | 11 | |||||
Other Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Liabilities Current | |||||||||||||||||
Accrued Income Taxes Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Convertible Notes Payable Current | - | - | - | - | - | - | - | - | 2 | 1 | 1 | 1 | |||||
Redeemable Noncontrolling Interest Equity Common C… | - | - | - | - | - | - | - | 1 | - | - | 2 | - | |||||
Accounts Payable Current | 8 | 8 | 7 | 7 | - | - | 5 | - | - | - | - | - | |||||
Sales And Excise Tax Payable Current | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Redeemable Noncontrolling Interest Equity Common R… | - | - | - | - | 1 | - | - | - | - | - | - | - | |||||
Accrued Liabilities Current | 6 | 6 | 6 | 8 | 2 | 1 | 4 | 1 | 1 | 1 | 0 | - | |||||
Convertible Debt Current | 8 | 7 | 4 | 4 | - | - | 46 | - | - | - | - | - | |||||
Notes Payable Current | 1 | 1 | 1 | 1 | - | - | 1 | - | - | - | - | - | |||||
Other Loans Payable Current | - | - | 1 | 1 | - | - | 1 | - | - | - | - | - | |||||
Convertible Longterm Note… | |||||||||||||||||
Liabilities Current | 28 | 29 | 22 | 24 | 16 | 13 | 57 | 5 | 4 | 4 | 5 | 3 | |||||
Deferred Income Tax Liabilities Net | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Warrants And Rights Outstanding | 0 | 0 | 0 | 0 | 7 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | |||||
Liabilities | 28 | 29 | 30 | 38 | 23 | 14 | 57 | 6 | 5 | 5 | 5 | 4 | |||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | 1 | 2 | 8 | 8 | 9 | 8 | 9 | 11 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 146 | 136 | 134 | 118 | - | - | 6 | - | - | - | - | - | |||||
Features Of Convertible P… | |||||||||||||||||
Temporary Equity Carrying Amount Including Portion… | - | - | - | - | - | - | 65 | - | - | - | - | - | |||||
Retained Earnings Accumulated Deficit | -173 | -164 | -161 | -152 | -23 | -14 | -125 | -5 | -5 | -4 | -3 | -3 | |||||
Stockholders Equity | -27 | -28 | -27 | -34 | -124 | -122 | -119 | -117 | -5 | -4 | -3 | -3 | |||||
Liabilities And Stockholders Equity | 1 | 1 | 4 | 4 | 2 | 2 | 3 | 9 | 9 | 8 | 11 | 11 | |||||
Temporary Equity Shares Issued | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | |||||
Temporary Equity Redemption Price Per Share | - | - | - | - | 13.07 | 12.83 | 12.13 | 11.84 | 11.59 | 11.34 | 11.1 | 10.9 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 1 | 1 | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Issued | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 600 | 600 | 600 | 600 | 100 | 100 | 600 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 0 | 2 | 1 | 42 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Shares Outstanding | 0 | 2 | 1 | 42 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Notes Payable | - | 2 | - | - | - | - | - | - | - | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -39.78% | -78.88% | -90.47% | - | - | - | - | - | - | - | - | - |
| 2025 | - | - | - | -43.65% | -39.04% | -55.99% | -9.47% | -44.38% | -65.68% | -22.17% | -59.58% | -85.82% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.03 | 0.02 | 0.17 | 0.18 | 0.04 | 0.00 | 0.00 | 0.13 | 0.03 | 0.02 | 0.32 | 0.05 | |||||
| Quick Ratio | 0.03 | 0.01 | 0.14 | 0.17 | 0.04 | 0.00 | 0.00 | 0.12 | 0.02 | 0.00 | 0.32 | 0.01 | |||||
| Working Capital | -27.33M | -28.36M | -18.49M | -19.35M | -15.49M | -13.19M | -56.87M | -4.48M | -4.04M | -3.90M | -3.35M | -2.85M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.04 | -1.03 | -1.14 | -1.13 | -0.19 | -0.12 | -0.48 | -0.05 | -1.01 | -1.03 | -1.47 | -1.05 | |||||
| Interest Coverage TTM | -137.20 | -21.57 | -10.99 | -4.58 | -0.92 | -0.98 | -1.02 | -2.13 | - | - | - | - | |||||
| Debt Ratio | 27.03 | 33.71 | 8.06 | 8.99 | 11.79 | 7.21 | 18.59 | 0.66 | 0.60 | 0.54 | 0.47 | 0.34 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.12 | 0.02 | 0.02 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -745.02 | -21.66 | -107.01 | -1.03 | -50,683.09 | -430.50 | -357.14 | -1.79 | -0.26 | -3.82 | 44.74 | 54.24 | |||||
| Free Cash Flow Per Share TTM | -318.40 | -10.84 | -48.54 | -0.34 | -7,671.59 | -89.85 | -79.94 | -1.12 | -0.29 | -53.11 | -79.51 | -73.13 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | - | - | - | -107,236.12% | -6,203.03% | -5,453.16% | -4,500.00% | -3,049.51% | - | -129.17% | -61.41% | -59.25% | |||||
| Net Profit Margin TTM | - | - | - | -131,084.94% | -13,076.24% | -11,125.72% | -9,230.00% | -4,638.39% | - | -8.35% | 47.30% | 57.33% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -100.00% | -100.00% | -100.00% | -66.67% | - | -91.59% | -95.93% | -96.95% | -100.00% | -56.35% | -54.56% | -54.56% | |||||
| Net Income Growth (1Y) | 228.61% | 228.63% | 288.11% | 842.03% | 869.23% | 11,108.44% | -894.38% | -346.99% | -138.12% | -102.55% | -83.79% | -78.93% | |||||
| EPS Growth (1Y) | -98.53% | -94.97% | -70.04% | -42.45% | 19,511,267.56% | 11,162.54% | -898.22% | -103.31% | -100.19% | -102.55% | -83.79% | -78.93% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.00 | -0.59 | -1.84 | -539.20 | - | - | - | - | - | - | - | - | |||||
| P/B TTM | -0.01 | -0.76 | -2.47 | -520.33 | - | - | - | - | - | - | - | - | |||||
| P/S TTM | - | - | - | 706,810.65 | - | - | - | - | - | - | - | - | |||||
| Market Cap | 168.70K | 21.40M | 65.91M | 17.67B | - | - | - | - | - | - | - | - | |||||
| Enterprise Value | 8.30M | 28.75M | 69.68M | 17.67B | - | - | - | - | - | - | - | - | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -18.36M | -18.29M | -16.25M | -10.82M | -1.98M | -2.32M | -2.07M | -2.17M | -1.50M | -1.38M | -2.06M | -1.90M | |||||
| Net Debt | 8.13M | 7.36M | 3.77M | 2.32M | -39.00K | -19.00K | 46.79M | -140.00K | 1.52M | 1.26M | 939.60K | 583.90K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Profusa, Inc. (PFSA) — SEC Financial Statements & Analysis
Profusa, Inc. (PFSA) is a surgical & medical instruments & apparatus company, incorporated in DE. Profusa, Inc. trades on Nasdaq, OTC as: PFSA, NVACW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Profusa, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of -1.04x, a Price-to-Sales (P/S) ratio of 706810.65x (TTM), a Price-to-Book (P/B) ratio of -0.01x (TTM), at a market cap of $168.70K. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Debt To Equity
- -1.04x
- P/S TTM
- 706810.65x
- P/B TTM
- -0.01x
- Market Cap
- $168.70K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Profusa, Inc. in?
Profusa, Inc. (PFSA) operates in the Surgical & Medical Instruments & Apparatus industry.
What is PFSA's market cap?
Profusa, Inc. (PFSA) has a market capitalization of $168.70K as of 2026-06-30.
What exchange does PFSA trade on?
Profusa, Inc. (PFSA) trades on the Nasdaq, OTC.
Where is Profusa, Inc. incorporated?
Profusa, Inc. is incorporated in DE.